Published in Infect Immun on February 01, 2001
A new name (Pneumocystis jiroveci) for Pneumocystis from humans. Emerg Infect Dis (2002) 2.57
Virulence-related surface glycoproteins in the yeast pathogen Candida glabrata are encoded in subtelomeric clusters and subject to RAP1- and SIR-dependent transcriptional silencing. Genes Dev (2003) 1.94
Colonization by Pneumocystis jirovecii and its role in disease. Clin Microbiol Rev (2012) 1.68
Selection of long oligonucleotides for gene expression microarrays using weighted rank-sum strategy. BMC Bioinformatics (2007) 1.45
Sub-grouping and sub-functionalization of the RIFIN multi-copy protein family. BMC Genomics (2008) 1.17
Enzyme-linked immunosorbent assay and serologic responses to Pneumocystis jiroveci. Emerg Infect Dis (2004) 1.09
Variation in the major surface glycoprotein genes in Pneumocystis jirovecii. J Infect Dis (2008) 1.03
Gene arrays at Pneumocystis carinii telomeres. Genetics (2005) 1.02
Human immunodeficiency virus-infected patients with prior Pneumocystis pneumonia exhibit increased serologic reactivity to several major surface glycoprotein clones. Clin Vaccine Immunol (2006) 0.99
Noninfectious entry of HIV-1 into peripheral and brain macrophages mediated by the mannose receptor. Proc Natl Acad Sci U S A (2007) 0.99
Candida albicans CUG mistranslation is a mechanism to create cell surface variation. MBio (2013) 0.97
Current understanding of Pneumocystis immunology. Future Microbiol (2010) 0.94
Serum antibody levels to the Pneumocystis jirovecii major surface glycoprotein in the diagnosis of P. jirovecii pneumonia in HIV+ patients. PLoS One (2010) 0.92
Evidence for high prevalence of Pneumocystis jirovecii exposure among Cameroonians. Acta Trop (2009) 0.90
Geographical variation in serological responses to recombinant Pneumocystis jirovecii major surface glycoprotein antigens. Clin Microbiol Infect (2009) 0.89
Discordant antibody and cellular responses to Pneumocystis major surface glycoprotein variants in mice. BMC Immunol (2012) 0.88
Pneumocystis murina MSG gene family and the structure of the locus associated with its transcription. Fungal Genet Biol (2007) 0.86
Functional differentiation of tbf1 orthologues in fission and budding yeasts. Eukaryot Cell (2008) 0.86
Complexity of the MSG gene family of Pneumocystis carinii. BMC Genomics (2009) 0.83
Serologic responses to recombinant Pneumocystis jirovecii major surface glycoprotein among Ugandan patients with respiratory symptoms. PLoS One (2012) 0.80
Genetic variation at the mitochondrial large-subunit rRNA locus of Pneumocystis isolates from simian immunodeficiency virus-infected rhesus macaques. Clin Diagn Lab Immunol (2003) 0.78
Analysis of Paramecium tetraurelia A-51 surface antigen gene mutants reveals positive-feedback mechanisms for maintenance of expression and temperature-induced activation. Eukaryot Cell (2005) 0.78
Pneumocystis jirovecii--from a commensal to pathogen: clinical and diagnostic review. Parasitol Res (2015) 0.77
Genetic characterization of the UCS and Kex1 loci of Pneumocystis jirovecii. Eur J Clin Microbiol Infect Dis (2008) 0.76
Pneumocystis. Cold Spring Harb Perspect Med (2014) 0.76
Subtelomere organization in the genome of the microsporidian Encephalitozoon cuniculi: patterns of repeated sequences and physicochemical signatures. BMC Genomics (2016) 0.75
Latent Pneumocystis infection of rats, relapse, and chemotherapy. Lab Invest (1966) 7.58
Pilus expression in Neisseria gonorrhoeae involves chromosomal rearrangement. Cell (1982) 7.19
Rapid switching to multiple antigenic and adhesive phenotypes in malaria. Nature (1992) 6.42
Antigenic variation in Lyme disease borreliae by promiscuous recombination of VMP-like sequence cassettes. Cell (1997) 6.36
Antigenic variation of Borrelia hermsii. J Exp Med (1982) 6.34
Linear plasmids of the bacterium Borrelia burgdorferi have covalently closed ends. Science (1987) 5.80
Isolation of the putative structural gene for the lysine-arginine-cleaving endopeptidase required for processing of yeast prepro-alpha-factor. Cell (1984) 5.26
Pneumocystis carinii pneumonia in the United States. Epidemiologic, diagnostic, and clinical features. Ann Intern Med (1974) 4.10
Unique phenotype of opaque cells in the white-opaque transition of Candida albicans. J Bacteriol (1987) 3.67
Activation of trypanosome surface glycoprotein genes involves a duplication-transposition leading to an altered 3' end. Cell (1981) 3.65
Requirement for CD4+ cells in resistance to Pneumocystis carinii pneumonia in mice. J Exp Med (1990) 3.20
Natural mode of acquisition for de novo infection with Pneumocystis carinii. J Infect Dis (1982) 2.80
Uptake of Pneumocystis carinii mediated by the macrophage mannose receptor. Nature (1991) 2.73
Gene duplication and transposition linked to antigenic variation in Trypanosoma brucei. Proc Natl Acad Sci U S A (1981) 2.66
Kinetics and in vivo induction of genetic variation of vlsE in Borrelia burgdorferi. Infect Immun (1998) 2.56
Serologic responses to Pneumocystis carinii antigens in health and disease. J Infect Dis (1990) 2.51
Antigenic variation of pilin regulates adhesion of Neisseria meningitidis to human epithelial cells. Mol Microbiol (1993) 2.44
Genetic variation among Pneumocystis carinii hominis isolates in recurrent pneumocystosis. J Infect Dis (1995) 2.35
Pneumocystis carinii and Toxoplasma gondii infections in patients with AIDS. Rev Infect Dis (1987) 2.19
Nude mouse: a new experimental model for Pneumocystis carinii infection. Science (1977) 2.16
Pneumocystis carinii organisms derived from rat and human hosts are genetically distinct. Mol Biochem Parasitol (1991) 2.09
Control of gene expression in trypanosomes. Microbiol Rev (1995) 2.06
The transposition unit of variant surface glycoprotein gene 118 of Trypanosoma brucei. Presence of repeated elements at its border and absence of promoter-associated sequences. J Mol Biol (1983) 1.98
DNA sequences identical to Pneumocystis carinii f. sp. carinii and Pneumocystis carinii f. sp. hominis in samples of air spora. J Clin Microbiol (1996) 1.98
A comparison of the antigenic characteristics of rat and human Pneumocystis carinii by immunoblotting. J Immunol (1987) 1.98
Gene conversion as a mechanism for antigenic variation in trypanosomes. Cell (1983) 1.97
Association of primary Pneumocystis carinii infection and sudden infant death syndrome. Clin Infect Dis (1999) 1.94
A search for Pneumocystis carinii in post-mortem lungs by DNA amplification. J Pathol (1992) 1.92
Properties of the major antigens of rat and human Pneumocystis carinii. Infect Immun (1989) 1.88
Juxtaposition of expressed variable antigen genes with a conserved telomere in the bacterium Borrelia hermsii. Proc Natl Acad Sci U S A (1990) 1.87
Identification of antigens and antibodies specific for Pneumocystis carinii. J Immunol (1988) 1.81
Analyses of rat Pneumocystis carinii antigens recognized by human and rat antibodies by using western immunoblotting. Infect Immun (1986) 1.81
Characterization of the DNA duplication-transposition that controls the expression of two genes for variant surface glycoproteins in Trypanosoma brucei. Nucleic Acids Res (1982) 1.79
High frequency of antigenic variation in Trypanosoma brucei rhodesiense infections. Parasitology (1989) 1.76
Experimental Pneumocystis carinii pneumonia in different strains of cortisonized mice. Infect Immun (1979) 1.75
Variability of a bacterial surface protein and disease expression in a possible mouse model of systemic Lyme borreliosis. J Exp Med (1994) 1.73
Host species-specific antigenic variation of a mannosylated surface glycoprotein of Pneumocystis carinii. J Infect Dis (1992) 1.69
Two modes of activation of a single surface antigen gene of Trypanosoma brucei. Cell (1984) 1.67
Variable antigen genes of the relapsing fever agent Borrelia hermsii are activated by promoter addition. Mol Microbiol (1991) 1.66
The expression-linked copy of a surface antigen gene in Trypanosoma is probably the one transcribed. Nature (1981) 1.60
Multiple genes encode the major surface glycoprotein of Pneumocystis carinii. J Biol Chem (1993) 1.59
Pneumocystis carinii carriage in immunocompetent patients with primary pulmonary disorders as detected by single or nested PCR. J Clin Microbiol (1999) 1.58
Telomere conversion in trypanosomes. Nucleic Acids Res (1983) 1.57
Repeated DNA in Pneumocystis carinii. J Clin Microbiol (1991) 1.57
Pneumocystis carinii is not universally transmissible between mammalian species. Infect Immun (1993) 1.55
The inactivation and reactivation of an expression-linked gene copy for a variant surface glycoprotein in Trypanosoma brucei. EMBO J (1984) 1.55
120-kD surface glycoprotein of Pneumocystis carinii is a ligand for surfactant protein A. J Clin Invest (1992) 1.53
The beta-tubulin gene from rat and human isolates of Pneumocystis carinii. Mol Microbiol (1992) 1.52
DNA rearrangements linked to expression of a predominant surface antigen gene of trypanosomes. Nature (1983) 1.52
Genetic stability and diversity of Pneumocystis carinii infecting rat colonies. Infect Immun (1993) 1.51
A role for RAD51 and homologous recombination in Trypanosoma brucei antigenic variation. Genes Dev (1999) 1.51
Transmission of Pneumocystis carinii DNA from a patient with P. carinii pneumonia to immunocompetent contact health care workers. J Clin Microbiol (2000) 1.50
Molecular genetic distinction of Pneumocystis carinii from rats and humans. J Eukaryot Microbiol (1994) 1.49
Limited persistence in and subsequent elimination of Pneumocystis carinii from the lungs after P. carinii pneumonia. J Infect Dis (1995) 1.47
Differential RNA elongation controls the variant surface glycoprotein gene expression sites of Trypanosoma brucei. Mol Microbiol (2000) 1.45
Antigen diversity in the bacterium B. hermsii through "somatic" mutations in rearranged vmp genes. Cell (1994) 1.44
Improved rat model of Pneumocystis carinii pneumonia: induced laboratory infections in Pneumocystis-free animals. Infect Immun (1992) 1.44
Antigenic variation in malaria. Cell (1995) 1.40
Molecular characterization of KEX1, a kexin-like protease in mouse Pneumocystis carinii. Gene (2000) 1.38
Role of fibronectin in Pneumocystis carinii attachment to cultured lung cells. J Clin Invest (1990) 1.37
Pneumocystis jiroveci n. sp. from man: morphology, physiology, and immunology in relation to pathology. Natl Cancer Inst Monogr (1976) 1.37
Activation and transmission in rats of infection with Pneumocystis. Proc Soc Exp Biol Med (1971) 1.36
Pneumocystis carinii in lungs of adults at autopsy. Am Rev Respir Dis (1968) 1.36
Purification and initial characterization of a ferret Pneumocystis carinii surface antigen. J Infect Dis (1988) 1.35
Predominance of duplicative VSG gene conversion in antigenic variation in African trypanosomes. Mol Cell Biol (1999) 1.34
Mechanisms of antigenic variation in Borrelia hermsii and African trypanosomes. J Biol Chem (1995) 1.34
Identification of Pneumocystis carinii chromosomes and mapping of five genes. Infect Immun (1990) 1.34
Pneumocystis carinii: what is it, exactly? Clin Microbiol Rev (1996) 1.33
Detection of Pneumocystis carinii among children with chronic respiratory disorders in the absence of HIV infection and immunodeficiency. J Med Microbiol (1998) 1.33
Sequences of Pneumocystis carinii f. sp. hominis strains associated with recurrent pneumonia vary at multiple loci. J Clin Microbiol (1997) 1.31
Expression and characterization of a cDNA clone encoding an immunodominant surface glycoprotein of Pneumocystis carinii. J Infect Dis (1992) 1.29
Continuous axenic cultivation of Pneumocystis carinii. Proc Natl Acad Sci U S A (1999) 1.29
Pneumocystis carinii attachment to cultured lung cells by pneumocystis gp 120, a fibronectin binding protein. J Clin Invest (1991) 1.29
Vitronectin binds to Pneumocystis carinii and mediates organism attachment to cultured lung epithelial cells. Infect Immun (1993) 1.28
Identification and isolation of a major cell surface glycoprotein of Pneumocystis carinii. Infect Immun (1989) 1.28
Active late-appearing variable surface antigen genes in Trypanosoma equiperdum are constructed entirely from pseudogenes. Proc Natl Acad Sci U S A (1989) 1.26
Molecular characterization of clustered variants of genes encoding major surface antigens of human Pneumocystis carinii. Infect Immun (1994) 1.26
Source of Pneumocystis carinii in recurrent episodes of pneumonia in AIDS patients. AIDS (1996) 1.26
Purification and characterization of a major human Pneumocystis carinii surface antigen. J Clin Invest (1991) 1.25
Pneumocystis carinii: immunoblotting and immunofluorescent analyses of serum antibodies during experimental rat infection and recovery. Exp Parasitol (1987) 1.25
Control of variant surface glycoprotein gene-expression sites in Trypanosoma brucei. EMBO J (1999) 1.24
Telomere exchange can be an important mechanism of variant surface glycoprotein gene switching in Trypanosoma brucei. Mol Biochem Parasitol (1996) 1.23
Structure and transcription of a telomeric surface antigen gene of Trypanosoma brucei. Mol Cell Biol (1985) 1.19
cDNA sequence diversity and genomic clusters of major surface glycoprotein genes of Pneumocystis carinii. J Infect Dis (1993) 1.18
Adoptive transfer of lymphocytes sensitized to the major surface glycoprotein of Pneumocystis carinii confers protection in the rat. J Clin Invest (1995) 1.18
Pneumocystis carinii glycoprotein A binds macrophage mannose receptors. Infect Immun (1995) 1.18
The role of transferrin-receptor variation in the host range of Trypanosoma brucei. Nature (1998) 1.17
An electrophoretic karyotype and assignment of ribosomal genes to resolved chromosomes of Pneumocystis carinii. Mol Microbiol (1989) 1.17
The identity of Pneumocystis carinii: not a single protozoan, but a diverse group of exotic fungi. Infect Agents Dis (1993) 1.16
Antigenic variation by positional control of major surface glycoprotein gene expression in Pneumocystis carinii. J Infect Dis (1995) 1.16
Revised nomenclature for Pneumocystis carinii. The Pneumocystis Workshop. J Eukaryot Microbiol (1995) 1.15
Changing the end: antigenic variation orchestrated at the telomeres of African trypanosomes. Trends Microbiol (1998) 1.15
Differentiation-associated surface antigen variation in the ancient eukaryote Giardia lamblia. Mol Microbiol (1998) 1.14
Immunization with the major surface glycoprotein of Pneumocystis carinii elicits a protective response. Vaccine (1998) 1.12
Animal models of pneumocystosis. FEMS Immunol Med Microbiol (1998) 1.12
Immunization with Pneumocystis carinii gpA is immunogenic but not protective in a mouse model of P. carinii pneumonia. Infect Immun (1998) 1.12
Telomeric reciprocal recombination as a possible mechanism for antigenic variation in trypanosomes. Nature (1985) 1.12
Carriage of Pneumocystis carinii by immunosuppressed patients and molecular typing of the organisms. AIDS (2000) 1.12
Glycoproteins composed of major surface immunodeterminants of Pneumocystis carinii. Infect Immun (1989) 1.12
Evolution of a trypanosome surface antigen gene repertoire linked to non-duplicative gene activation. Nature (1984) 1.10
Genetic variation in Pneumocystis carinii isolates from different geographic regions: implications for transmission. Emerg Infect Dis (2000) 2.08
Time between inoculations and karyotype forms of Pneumocystis carinii f. sp. Carinii influence outcome of experimental coinfections in rats. Infect Immun (2001) 0.89
Expression and complexity of the PRT1 multigene family of Pneumocystis carinii. Microbiology (2004) 0.89
Similar subclass antibody responses after intranasal immunization with UV-inactivated RSV mixed with cholera toxin or live RSV. J Med Virol (1991) 0.85
Rapid recovery in mice after combined nasal/oral immunization with killed respiratory syncytial virus. J Med Virol (1990) 0.82
Comparison of class and subclass antibody response to live and UV-inactivated RSV administered intranasally in mice. J Med Virol (1991) 0.82
Influenza-specific ELISA IgA and IgG predict severity of influenza disease in subjects prescreened with hemagglutination inhibition. Antiviral Res (1990) 0.80
Genetic and antigenic variation in Pneumocystis carinii organisms: tools for examining the epidemiology and pathogenesis of infection. J Lab Clin Med (1997) 0.80
The use of genetic markers to characterize transmission of Pneumocystis carinii. AIDS Patient Care STDS (1997) 0.79
The minimum number of Pneumocystis carinii f. sp. carinii organisms required to establish infections is very low. J Eukaryot Microbiol (1999) 0.78
Isolation and characterization of mouse nasal lymphocytes. J Immunol Methods (1989) 0.77
Development and evaluation of an off-the-slide genotyping technique for identifying Giardia cysts and Cryptosporidium oocysts directly from US EPA Method 1623 slides. J Appl Microbiol (2013) 0.77
Identification of porcine Pneumocystis carinii as a genetically distinct organism by DNA amplification. APMIS (1997) 0.76
Misinformation about Pneumocystis. Clin Exp Dermatol (2009) 0.75
Differential effect of amantadine hydrochloride on the systemic and local immune response to influenza A. J Med Virol (1989) 0.75